Company News
Emcure's Poviztra Gets CDSCO Nod for MASH
Emcure Pharmaceuticals announces CDSCO approval for Poviztra® to treat non-cirrhotic MASH in adults with liver fibrosis.
The approval, based on Phase III ESSENCE trial results, addresses a significant
